Urolithin A attenuates osteoclast differentiation and compensates for ovariectomy-induced bone loss in mice by inhibiting PI3K/AKT/mTOR signaling pathway
Backgrounds and purposes: Osteoporosis (OP) is a debilitating illness distinguished by a reduction in bone density and microstructure, which leads to fragility, fracture risk, and increased mortality, particularly in the elderly and postmenopausal women. Growing evidence suggests that various plant...
Saved in:
Main Authors: | Wenyun Zhou (Author), Weijun Zhou (Author), Zibin Zhou (Author), Yonghao Bi (Author), Zhigao Zhou (Author), Shaozhe Chen (Author), Zihong Lin (Author), Jiajie Ye (Author), Gang Xie (Author), Wenjie Liu (Author), Dantao Xie (Author), Zhen Lian (Author), Ruiwu Zheng (Author), Xianghua Hu (Author), Xinjia Wang (Author), Guixin Yuan (Author), Guanfeng Yao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
6'-O-Galloylpaeoniflorin Attenuates Osteoclasto-genesis and Relieves Ovariectomy-Induced Osteoporosis by Inhibiting Reactive Oxygen Species and MAPKs/c-Fos/NFATc1 Signaling Pathway
by: Wenjie Liu, et al.
Published: (2021) -
Oroxin B Attenuates Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Formation and Activity
by: Huang JM, et al.
Published: (2021) -
Isoliensinine Suppresses Osteoclast Formation Through NF-κB Signaling Pathways and Relieves Ovariectomy-Induced Bone Loss
by: Huijiang Liu, et al.
Published: (2022) -
Study on the biological mechanism of urolithin a on nasopharyngeal carcinoma in vitro
by: Yang Yang, et al.
Published: (2022) -
Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo
by: Sun P, et al.
Published: (2020)